Pharmacy preceptor and alumnus Lucius Daniel '93 appointed to NCODA Executive Council

Lucius Daniel, PharmD
Wayne State pharmacy alumnus Lucius Daniel, PharmD, ACE, helps train current PharmD students as preceptor at Karmanos Specialty Pharmacy.

Wayne State University pharmacy preceptor and alumnus Lucius Daniel, PharmD, ACE, was appointed to the National Community Oncology Dispensing Association (NCODA) Executive Council.

NCODA is a grassroots, not-for-profit organization founded to strengthen community oncology practices. It addresses the growing need for dispensing cancer clinics to improve operations at the pharmacy level in order to deliver quality and sustainable value to all stakeholders involved in the care of cancer patients receiving oral therapies.

In his role as lead clinical specialist at the Karmanos Specialty Pharmacy (KSP), Dr. Daniel helps coordinate the clinical care delivered by the pharmacy team. He has been instrumental in reorganizing operations to enhance these quality standards which ultimately benefit all KSP patients.

In a NCODA press release, President Jim Schwartz, RPh, said, "NCODA has added another skilled and well-respected cancer care professional to our Executive Council. Lucius is well-positioned to help us continue executing on our mission in 2021."

NCODA Founder and Executive Director Michael Reff, RPh, MBA, noted, "Lucius has extensive experience working in an integrated delivery network. As NCODA grows, it is important that the organization has leaders with unique backgrounds and experiences so that we can continue to shape the cancer care landscape - and do it in a way that is patient-centered and always collaborative."

Daniel earned his B.S. in Pharmacy from Wayne State in 1993 and his PharmD at the University of Florida-Gainesville. He began his career in the pharmaceutical industry with Eli Lilly and Company, and later transitioned Merck and Company as the regional health science associate covering a large geography in Michigan. Daniel also has experience in retail pharmacy and before joining the team at Karmanos Cancer Center held a position at McLaren Oakland as the 340(b) program manager.

Since joining the specialty pharmacy team at Karmanos, Daniel has been involved in establishing the initial activities with specialty pharmacy. These activities range from oral oncolytic product procurement within limited distribution networks, to involvement with all planning activities associated with bringing KSP online. Additionally, he has been able to forge strong collaborative relationships with all the MDT teams at Karmanos Cancer Center Network. He has also been instrumental in helping the KSP team manage oral chemotherapy with a focus side effect management, improving medication adherence, and aiding care teams by documenting clinical information back to MDT care teams.

Daniel has spearheaded the development of policies and procedures, established clinical pharmacy protocols with physicians that have been useful in prior authorization processes, and aided in reducing treatment gaps for inpatient hematology cases. He has compiled documentation for URAC accreditation, streamlined processes related to workflow and prescription order processing, created a protocol to identifying oral oncolytic copay funding mechanisms, and developed the current KSP workforce.

← Back to listing